4.5 Article

Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

期刊

JOURNAL OF CLINICAL PSYCHIATRY
卷 71, 期 3, 页码 296-303

出版社

PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.09m05514yel

关键词

-

资金

  1. Eli Lilly
  2. Elan/Eisai
  3. AstraZeneca
  4. Bristol-Myers Squibb
  5. Pfizer
  6. Proteus Biomedical
  7. GlaxoSmithKline
  8. Concordant Rater Systems
  9. Alcoholism
  10. Alcohol Abuse
  11. Massachusetts General Psychiatry Academy (MGHPA)
  12. Janssen Pharmaceuticals
  13. Cyberonics
  14. MedAvante
  15. Transcept
  16. Supernus
  17. Shire
  18. Forest
  19. Cederroth
  20. Stanley Foundation
  21. Broad Institute
  22. Pam Labs
  23. NARSAD Young Investigator Award
  24. Sydney L. Baer Foundation Award
  25. Bowman Family Foundation Award
  26. NIMH, National Institutes of Health [N01MH80001]

向作者/读者索取更多资源

Background: Poor medication adherence is common among bipolar patients. Method: We examined prospective data from 2 cohorts of individuals from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (1999-2005) with bipolar disorder. Clinical and sociodemographic features associated with missing at least 25% of doses of at least 1 medication were assessed using logistic regression, and a risk stratification model was developed and validated. Results: Of 3,640 subjects with 48,287 follow-up visits, 871 (24%) reported nonadherence on 20% or more study visits. Clinical features significantly associated (P<.05) with poor adherence included rapid cycling, suicide attempts, earlier onset of illness, and current anxiety or alcohol use disorder. Nonadherence during the first 3 months of follow-up was associated with less improvement in functioning at 12-month follow-up (P<.03). A risk stratification model using clinical predictors accurately classified 80.6% of visits in an independent validation cohort. Conclusion: Risk for poor medication adherence can be estimated and may be useful in targeting interventions. J Clin Psychiatry 2010;71(3):296-303 (C) Copyright 2010 Physicians Postgraduate Press, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据